Literature DB >> 7927942

Pre-morbid body size and the prognosis of women with breast cancer.

M Jain1, A B Miller.   

Abstract

Obesity has been associated with poor prognosis of breast cancer, but studies investigating indicators of adiposity, independent of height, such as skinfold thickness and weight/height ratio, have been limited. From a cohort of 89,835 women in the National Breast Screening Study, data on histologically confirmed, incident cases of invasive carcinoma of breast, diagnosed between January 1981 to June 1992, were analyzed. Body measurements were taken at enrollment and other risk-factor information from a self-administered questionnaire completed prior to diagnosis of the breast cancer. Mortality data were obtained by linkage to Statistics Canada, provincial cancer registries, and annual follow-up of cases through physicians. Of the 5 measures of body size studied among cases, poor prognosis was associated with higher triceps skinfold thickness only. With every 5 mm increase in skinfold, the risk of dying increased approximately 12% (relative risk, 1.12; 95% confidence intervals, 1.01 to 1.24) in the 1033 cases examined and adjusted for age at diagnosis, number of positive axillary nodes involved, and body weight. Compared with women in the lowest quartile of skinfold thickness, women in the fourth quartile had a relative risk (RR) of 1.64 (95% CI, 0.99 to 2.73). None of the other measures--weight, height, body mass index or weight/height ratio--reached any statistical significance. Since the reliability and validity of skinfold measures used in our study were never established, and no data were available for changes in body size after diagnosis, the results of this study on skinfold thickness should be used only as indicative of a need for further studies.

Entities:  

Mesh:

Year:  1994        PMID: 7927942     DOI: 10.1002/ijc.2910590312

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  BMI influences prognosis following surgery and adjuvant chemotherapy for lymph node positive breast cancer.

Authors:  Mara Z Vitolins; Gretchen G Kimmick; L Douglas Case
Journal:  Breast J       Date:  2008 Jul-Aug       Impact factor: 2.431

2.  Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer.

Authors:  Chaminda Sellahewa; Peter Nightingale; Amtul R Carmichael
Journal:  Int Semin Surg Oncol       Date:  2008-02-24

3.  Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.

Authors:  J Mark Elwood; Sandar Tin Tin; Marion Kuper-Hommel; Ross Lawrenson; Ian Campbell
Journal:  BMC Cancer       Date:  2018-01-15       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.